Handelsbanken Fonder Ab Silk Road Medical Inc Transaction History

Handelsbanken Fonder Ab

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$29.76 - $46.14 $5,952 - $9,228	200 Added 2.94%	7,000 $227,000
Q4 2022 Feb 07, 2023	BUY	$40.54 - $56.2 $24,324 - $33,720	600 Added 9.68%	6,800 $359,000
Q2 2022 Aug 03, 2022	BUY	$28.03 - $45.8 $25,227 - $41,220	900 Added 16.98%	6,200 $226,000
Q1 2022 May 11, 2022	SELL	$29.24 - $44.06 $84,796 - $127,774	-2,900 Reduced 35.37%	5,300 $219,000
Q4 2021 Feb 08, 2022	SELL	$39.32 - $61.61 $11,796 - $18,483	-300 Reduced 3.53%	8,200 $349,000
Q2 2021 Aug 03, 2021	BUY	$44.66 - $63.06 $133,980 - $189,180	3,000 Added 54.55%	8,500 $407,000
Q4 2020 Feb 11, 2021	BUY	$55.51 - $69.94 $305,305 - $384,670	5,500 New	5,500 $346,000

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.